Arenicins are a group of antimicrobial peptides being studied to combat Gram-negative bacteria. The arenicin family consists of three different peptides: arenicin-1, arenicin-2, and the most recently discovered, arencin-3. Adenium Biotech currently remains in the preclinical testing period of their product, arenicin-3. Toxicology, drug efficacy, and other information have yet to be determined with further research completed in clinical settings. However, with Gram-negative bacteria causing 65% of hospital-acquired infections, the commercial market for arenicin is large.
Property | Value |
---|---|
dbo:abstract |
|
dbo:symbol |
|
dbo:wikiPageID |
|
dbo:wikiPageLength |
|
dbo:wikiPageRevisionID |
|
dbo:wikiPageWikiLink |
|
dbp:name |
|
dbp:opmFamily |
|
dbp:opmProtein |
|
dbp:symbol |
|
dbp:tcdb |
|
dbp:wikiPageUsesTemplate | |
dcterms:subject | |
gold:hypernym | |
rdf:type |
|
rdfs:comment |
|
rdfs:label |
|
owl:sameAs | |
prov:wasDerivedFrom | |
foaf:isPrimaryTopicOf | |
is foaf:primaryTopic of |